The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo | |
Ren, Peijun; Zou, Gang; Bailly, Benjamin; Xu, Shanshan; Zeng, Mei; Chen, Xinsheng; Shen, Liang; Zhang, Ying; Guillon, Patrice; Arenzana-Seisdedos, Fernando | |
刊名 | EMERGING MICROBES & INFECTIONS |
2014 | |
卷号 | 3 |
关键词 | anti-viral drug discovery enterovirus 71 hand, foot and mouth disease suramin |
ISSN号 | 2222-1751 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4883692 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Ren, Peijun,Zou, Gang,Bailly, Benjamin,et al. The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo[J]. EMERGING MICROBES & INFECTIONS,2014,3. |
APA | Ren, Peijun.,Zou, Gang.,Bailly, Benjamin.,Xu, Shanshan.,Zeng, Mei.,...&Altmeyer, Ralf.(2014).The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo.EMERGING MICROBES & INFECTIONS,3. |
MLA | Ren, Peijun,et al."The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo".EMERGING MICROBES & INFECTIONS 3(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论